Back to search

Progressive Reversion of Human Immunodeficiency Virus Type 1 Resistance Mutations In Vivo after Transmission of a Multiply Drug-Resistant Virus

Data up to Jan 2025

Published2003
Citations123
References21

Total Citations Per Year

Abstract

References (21)

Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

1998 • 9,382 citations

Changing patterns of mortality across Europe in patients infected with HIV-1

1998 • 1,284 citations

Antiretroviral-Drug Resistance among Patients Recently Infected with HIV

2002 • 1,150 citations

Immune control of HIV-1 after early treatment of acute infection

2000 • 1,012 citations

Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia

2001 • 657 citations

A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

2000 • 641 citations

Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination Therapy

1995 • 637 citations

Antiretroviral Drug Resistance Testing in Adults Infected with Human Immunodeficiency Virus Type 1: 2003 Recommendations of an International AIDS Society–USA Panel

2003 • 524 citations

Time Trends in Primary HIV-1 Drug Resistance Among Recently Infected Persons

2002 • 466 citations

Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

1999 • 400 citations

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy

1999 • 287 citations

In vitroSelection and Characterization of HIV-1 with Reduced Susceptibility to PMPA

1999 • 251 citations

Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection

2002 • 219 citations

Interruption of reverse transcriptase inhibitors or a switch from reverse transcriptase to protease inhibitors resulted in a fast reappearance of virus strains with a reverse transcriptase inhibitor-sensitive genotype

1999 • 153 citations

Human Immunodeficiency Virus Type 1 Expressing the Lamivudine‐Associated M184V Mutation in Reverse Transcriptase Shows Increased Susceptibility to Adefovir and Decreased Replication Capability In Vitro

1999 • 137 citations

Comparative Fitness of Multi-Dideoxynucleoside-Resistant Human Immunodeficiency Virus Type 1 (HIV-1) in an In Vitro Competitive HIV-1 Replication Assay

1999 • 127 citations

Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215

1997 • 125 citations

Establishment of New Transmissible and Drug-Sensitive Human Immunodeficiency Virus Type 1 Wild Types due to Transmission of Nucleoside Analogue-Resistant Virus

2001 • 121 citations

Amprenavir-resistant HIV-1 exhibits lopinavir cross-resistance and reduced replication capacity

2002 • 106 citations

Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

2000 • 86 citations

Fitness of Human Immunodeficiency Virus Type 1 Protease Inhibitor-Selected Single Mutants

2000 • 80 citations

Cited By (0)

Loading...